Mr.Liu Chengwei, was appointed Executive Director of the Company in July 2008, is the Chairman of the Company and is a director of Grand Pharm (China), the principal subsidiary of the Company. Mr. Liu is also a director of Huadong Medicine, the shares of which are listed on the main board of Shenzhen Stock Exchange. Mr. Liu has over 20 years of financial and management experience in the PRC. He joined China Grand Enterprise (“CGE”) in 2001 and is currently the assistant president and director of CGE. Mr. Liu obtained his bachelor degree in International Economics from Peking University and master degree in Business Administration from China Europe International Business School.
Mr. Hu Bo
was appointed executive director of the company in July 2008. Mr. Hu has over 5 years of experience in network project management and property management. He is currently the deputy general manager of a real estate company in the PRC. Mr. Hu holds a bachelor degree in Applied Science & Engineering, Electrical Engineering from University of Toronto. Mr. Hu is a nephew of Mr. Hu Kaijun, the beneficial owner of Outwit, which is the controlling shareholder of the Company.
Dr. Shao Yan
Chief Executive Officer
was appointed executive director of the Company in October 2008. Dr. Shao joined the Company in March 2008 and is the Chief Executive Officer of the Company. Dr. Shao is responsible for overseeing the entire operations and general management of the Company. He has over 20 years of experience in corporate management and venture capital investment. He hold a master’s degree in Business Administration from Guanghua School of Management of Peking University and a doctor degree (PhD) in Management from School of Politics and international Studies of Beijing Normal University.
Dr. Niu Zhanqi
Dr. Niu Zhanqi, aged 49, holds a bachelor degree of science from Nankai University and a doctorate (PhD) degree in pharmacy from Shenyang Pharmaceutical University. Dr. Niu has over ten years of medical research and development experience. He currently serves as Executive President of the Pharmaceutical Management Head Office of China Grand Enterprises Incorporation. He is also Director of Huadong Medicine Co., Ltd. (a company listed on the Shenzhen Stock Exchange, stock code: 000963) since June 2016.
was appointed independent non-executive director of the Company in March 2005. Ms So is a fellow member of the Association of Chartered Certified Accountants and a practicing member of the Hong Kong Institute of Certified Public Accountants. She is a partner of an accounting firm.
Mr. Hu Yebi
Independent Non-Executive Director
Mr. Hu Yebi, received his Master of Business Administration from Netherlands International Institute for Management in the Netherlands and a Postgraduate Diploma in Management Engineering from Beijing Institute of Technology in Beijing, the PRC. Mr. Hu has more than twenty years of experience in securities and financial services, mergers and acquisitions and corporate finance. Mr. Hu is the founder and chairman of Vision Finance Group Limited. Mr. Hu is currently a non-executive director of Beijing Sports and Entertainment Industry Group Limited (stock code: 1803) and was an executive director of Tai United Holdings Limited (stock code: 718), Hua Lien International (Holding) Company Limited (stock code: 969), Beijing Enterprises Medical and Health Industry Limited (stock code: 2389) and Beijing Properties (Holdings) Limited (stock code: 925), but already resigned in October 2016, July 2017, October 2018 and November 2018 respectively. All these companies are listed on The Stock Exchange of Hong Kong Limited.
Dr. Pei Geng
Independent Non-Executive Director
Dr. Pei Geng is currently working in Multiway Trading Intl., USA and its Beijing branch, with TDR company in the USA. Dr. Pei has specialized in the areas of neurosurgery and neuroscience for over 20 years. Dr. Pei holds a bachelor degree in Medicine and became a clinician after graduation from Capital Medical University, Beijing, China. Dr. Pei also holds a licentiate degree in Medical Sciences from Uppsala University of Medicine, Sweden and a PhD degree in neuroscience from University of Würzburg, Germany.